Global Amniocentesis Needles Market, By Product Type (100mm to 150mm, Smaller Than 100 mm, and Larger Than 150 mm), By Application (Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion, and Cordocentesis), By End User (Hospitals, Diagnostic Centers, and Clinics), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 154.4 million in 2018, and is projected to exhibit a CAGR of 3.8% over the forecast period (2019 - 2026).
Amniocentesis needles are manufactured for perceivable sampling in before birth diagnosis of the child. Usually, one centimeter of spiral grooving on the distal tip offers a reflective uppermost periphery for improved visualization, monitored through ultrasound enlightenment. The manufacturers of the amniocentesis needles are majorly involved in producing convenient type of needles, which will be safe and easy to handle to avoid complications during the procedure. According to the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) report of 2016, ideally a 20-22 Gauge needle should be inserted transabdominally under continuous ultrasound guidance, which is considered as the safest method and does not cause harm to the fetus and the mother. For instance, the Cook Medicals product portfolio of amniocentesis needles contains 8 type of amniocentesis needles which is accurately manufactured according to the guidelines of ISUOG.
Increasing rate of child-birth is significantly driving the global amniocentesis needle market growth. The rising rate of childbirths also requires prenatal diagnosis to know about the health of child. Amniocentesis test reveals every information regarding the fetus such as sex, genetic abnormality, and blood disorder. For instance, Centers for Disease Control and Prevention (CDC) reported in 2017, 3.9 million live child-birth occurred in the U.S. The global amniocentesis needle market size is expected to increase, owing to merger and acquisitions of major manufacturers of amniocentesis companies. Major companies in the industry are working on acquiring the product portfolios of other companies to increase their market share. For instance, in April 2016, Cooper Surgical, acquired Genesis Genetics, a genetics laboratory specializing in pre-implantation genetic screening (PGS) and pre-implantation genetic diagnosis (PGD) used during the in-vitro fertilization (IVF) process. The Cooper Surgical is continuously expanding its business in women’s health portfolio. For instance, in November 2016, Cooper Surgical acquired Wallace, the in-vitro fertilization (IVF) segment of Smiths Medical, a division of Smiths Group plc, for a purchase price of around US $168 million to strengthen product portfolio and takeover premier products for women’s health.
Browse 29 Market Data Tables and 17 Figures spread through 166 Pages and in-depth TOC on "Global Amniocentesis Needles Market, By Product Type (100mm to 150mm, Smaller Than 100 mm, and Larger Than 150 mm), By Application (Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion, and Cordocentesis) By End User (Hospitals, Diagnostic Centers, and Clinics), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2026"
To know the latest trends and insights related to amniocentesis needles market, click the link below:
Key Takeaways of the Global Amniocentesis Needles Market: